HOXA13 and central nervous system cancer: The down-regulation of HOXA13 in glioma cells resulted in a marked decrease in cell invasion in Transwell assays compared to the control cell type, and this effect was more significant in the U87 and U87-EGFRvIII cell lines (Figure 6A).